Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.